Abiopharma

General Announcement: Allotment and Issuance of Shares Pursuant to the Exercise of Options

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest of Director

Trustee’s report for BONDS 2 for the period from 15.9.25 to 31.12.25

General Announcement: Proposed Renounceable Non-Underwritten Right Issue - Application of Whitewash Waiver to SIC

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer

Change - Change in Corporate Information: Additional investment in wholly-owned subsidiary, F J Benjamin (Singapore) Pte Ltd

The trustee report for the BONDS (Series 1) for 2025, Mishmeret

Employee Stock Option/ Share Scheme: Notice of Use of Treasury Shares